ClinicalTrials.Veeva

Menu

Viral and Host Factors in the Transmission and Pathogenesis of HIV

Rockefeller University logo

Rockefeller University

Status

Terminated

Conditions

HIV Infections

Treatments

Other: blood draw

Study type

Observational

Funder types

Other

Identifiers

NCT00219947
MMA-448

Details and patient eligibility

About

To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV.

The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.

Full description

This phlebotomy protocol permits the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV.

Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for one or all of the following tests:

  • T cell subset enumeration
  • Serologic reactivity with HIV antigens
  • Viral load assays by bDNA, PCR, or RT-PCR
  • Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR)
  • HIV-1 Resistance Testing

These data are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines

Enrollment

600 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

recently infected with HIV-1 HIV-1 negative, and at high risk for infection

Exclusion criteria

none

Trial design

600 participants in 2 patient groups

high risk
Description:
Blood draw from individuals known to be or at high risk for HIV-infection
Treatment:
Other: blood draw
diagnosed
Description:
Blood draw f rom individuals diagnosed with HIV infection
Treatment:
Other: blood draw

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems